Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03162224
Title Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site San Francisco California 94115 United States Details
Research Site Orlando Florida 32806 United States Details
Research Site Atlanta Georgia 30308 United States Details
Research Site Indianapolis Indiana 46202 United States Details
Research Site Baltimore Maryland 21201 United States Details
Research Site Baltimore Maryland 21287 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Minneapolis Minnesota 55414 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site Morristown New Jersey 07960 United States Details
Research Site Bronx New York 10461 United States Details
Research Site Winston-Salem North Carolina 27157 United States Details
Research Site Columbus Ohio 43210 United States Details
Research Site Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field